Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 4
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Gutiérrez-Gutiérrez B, Del Toro MD, Borobia AM, Carcas A, Jarrín I, Yllescas M, Ryan P, Pachón J, Carratalà J, Berenguer J, Arribas JR, Rodríguez-Baño J; REIPI-SEIMC COVID-19 group and COVID@HULP groups. Gutiérrez-Gutiérrez B, et al. Lancet Infect Dis. 2021 Jun;21(6):783-792. doi: 10.1016/S1473-3099(21)00019-0. Epub 2021 Feb 23. Lancet Infect Dis. 2021. PMID: 33636145 Free PMC article.
N-acetylcysteine as an antidote for paracetamol poisoning: a multicenter study.
Codinach-Martín M, Ortega-Pérez J, Gispert-Ametller MÀ, Salgado-García E, Rodríguez-Mariblanca A, Nogué-Xarau S, Puiguriguer-Ferrando J. Codinach-Martín M, et al. Among authors: rodriguez mariblanca a. Emergencias. 2022 Jun;34(3):190-195. Emergencias. 2022. PMID: 35736523 Free article. English, Spanish.
Acute Poisoning Readmissions to an Emergency Department of a Tertiary Hospital: Evaluation through an Active Toxicovigilance Program.
Muñoz Romo R, Borobia Pérez AM, Mayayo Alvira R, Urroz M, Rodríguez Mariblanca A, Guijarro Eguinoa FJ, Diaz García L, Cobo Mora J, Rivera A, Torres R, Carcas Sansuán AJ. Muñoz Romo R, et al. Among authors: rodriguez mariblanca a. J Clin Med. 2022 Aug 2;11(15):4508. doi: 10.3390/jcm11154508. J Clin Med. 2022. PMID: 35956123 Free PMC article.
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation.
García-García I, Dapía I, Montserrat J, Martinez de Soto L, Bueno D, Díaz L, Queiruga J, Rodriguez Mariblanca A, Guerra-García P, Ramirez E, Frías J, Pérez Martínez A, Carcas-Sansuan AJ, Borobia AM. García-García I, et al. Among authors: rodriguez mariblanca a. Front Pharmacol. 2021 Oct 20;12:717932. doi: 10.3389/fphar.2021.717932. eCollection 2021. Front Pharmacol. 2021. PMID: 34744712 Free PMC article.
Health Care Workers' Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study.
Borobia AM, García-García I, Díaz-García L, Rodríguez-Mariblanca A, Martínez de Soto L, Monserrat Villatoro J, Seco Meseguer E, González JJ, Frías Iniesta J, Ramírez García E, Arribas JR, Carcas-Sansuán AJ. Borobia AM, et al. Among authors: rodriguez mariblanca a. J Med Internet Res. 2021 Feb 25;23(2):e23441. doi: 10.2196/23441. J Med Internet Res. 2021. PMID: 33556032 Free PMC article.
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
García IG, Rodriguez-Rubio M, Mariblanca AR, de Soto LM, García LD, Villatoro JM, Parada JQ, Meseguer ES, Rosales MJ, González J, Arribas JR, Carcas AJ, de la Oliva P, Borobia AM. García IG, et al. Among authors: mariblanca ar. Trials. 2020 Jun 3;21(1):466. doi: 10.1186/s13063-020-04436-6. Trials. 2020. PMID: 32493475 Free PMC article.